Concord Drugs (538965)
FAST GROWERScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹38.84 |
| Market Cap | ₹39.21 Cr |
| P/E Ratio | 149.06 |
| ROCE | 4.73% |
| ROE | -19.57% |
| Dividend Yield | 0% |
| Profit Growth | 0% |
| Debt/Equity | — |
| Sales Growth | 56.36% |
| 52-Week Range | ₹29 — ₹92.52 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹35.75 |
Concord Drugs trades with a P/E ratio of 149.06, ROCE of 4.73%, ROE of -19.57%.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer